Back to Search
Start Over
522 Targeting HER2 with trastuzumab-DM1 (T-DM1) is highly effective in preclinical models of HER2-overexpressing bladder cancer.
- Source :
-
European Urology Supplements . Apr2014, Vol. 13 Issue 1, pe522-e522. 1p. - Publication Year :
- 2014
Details
- Language :
- English
- ISSN :
- 15699056
- Volume :
- 13
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- European Urology Supplements
- Publication Type :
- Academic Journal
- Accession number :
- 95715645
- Full Text :
- https://doi.org/10.1016/S1569-9056(14)60514-5